Literature DB >> 21901400

The age at onset of psychosis and tobacco use: a systematic meta-analysis.

Nicholas Myles1, Hannah Newall, Michael T Compton, Jackie Curtis, Olav Nielssen, Matthew Large.   

Abstract

BACKGROUND: There is a well-established but poorly understood association between tobacco use and psychotic illness. The aim of this study was to determine whether tobacco use is associated with an earlier age at onset of psychotic illness.
METHODS: Peer-reviewed publications in English reporting the age at onset of psychosis in tobacco-using and non-tobacco-using groups were located using searches of CINAHL, EMBASE, MEDLINE, PsycINFO and ISI Web of Science, and were supplemented by papers located by manual searches and unpublished data obtained by correspondence with primary researchers. A total of 29 samples reported age at onset data in a consecutive series of patients with a diagnosis of schizophrenia related psychosis or first episode psychosis. Information on study design, study population and effect size was extracted independently by three authors. A random effects meta-analysis was performed.
RESULTS: There was no significant difference between smokers and non-smokers in age at the onset of psychosis (standardized mean difference = -0.03).
CONCLUSION: Unlike cannabis use, tobacco use is not associated with an earlier onset of psychosis.

Entities:  

Mesh:

Year:  2011        PMID: 21901400     DOI: 10.1007/s00127-011-0431-3

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  25 in total

1.  Does smoking cause schizophrenia?

Authors:  P Hays
Journal:  Can J Psychiatry       Date:  2000-12       Impact factor: 4.356

2.  Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.

Authors:  S Duval; R Tweedie
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

3.  Course of substance misuse and daily tobacco use in first-episode psychosis.

Authors:  Darryl Wade; Susy Harrigan; Jane Edwards; Philip M Burgess; Greg Whelan; Patrick D McGorry
Journal:  Schizophr Res       Date:  2005-11-17       Impact factor: 4.939

4.  Self-reported psychotic symptoms in the general population: results from the longitudinal study of the British National Psychiatric Morbidity Survey.

Authors:  Nicola J Wiles; Stanley Zammit; Paul Bebbington; Nicola Singleton; Howard Meltzer; Glyn Lewis
Journal:  Br J Psychiatry       Date:  2006-06       Impact factor: 9.319

Review 5.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 6.  Cannabis use and earlier onset of psychosis: a systematic meta-analysis.

Authors:  Matthew Large; Swapnil Sharma; Michael T Compton; Tim Slade; Olav Nielssen
Journal:  Arch Gen Psychiatry       Date:  2011-02-07

7.  Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.

Authors:  Michael T Compton; Mary E Kelley; Claire E Ramsay; Makenya Pringle; Sandra M Goulding; Michelle L Esterberg; Tarianna Stewart; Elaine F Walker
Journal:  Am J Psychiatry       Date:  2009-10-01       Impact factor: 18.112

8.  Investigating the association between cigarette smoking and schizophrenia in a cohort study.

Authors:  Stanley Zammit; Peter Allebeck; Christina Dalman; Ingvar Lundberg; Tomas Hemmingsson; Glyn Lewis
Journal:  Am J Psychiatry       Date:  2003-12       Impact factor: 18.112

9.  Physical illness and lifestyle risk factors in people with their first presentation of psychosis.

Authors:  Chiara Samele; Maxine Patel; Jane Boydell; Morven Leese; Simon Wessely; Robin Murray
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-11-23       Impact factor: 4.519

Review 10.  Health habits of patients with schizophrenia.

Authors:  Christiane Roick; Anita Fritz-Wieacker; Herbert Matschinger; Dirk Heider; Jana Schindler; Steffi Riedel-Heller; Matthias C Angermeyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-02-13       Impact factor: 4.519

View more
  5 in total

1.  Characteristics and Predictors of Intention to use Cessation Treatment among Smokers with Schizophrenia: Young Adults Compared to Older Adults.

Authors:  Mary F Brunette; Joelle C Feiron; Kelly Aschbrenner; Daniel Colctti; Timothy Devitt; Mary Ann Greene; Amy Harrington; Gregory C MoHugo; Samh Pratt; Delbert Robinson; Jill Williams; Haiyi Xie
Journal:  J Subst Abus Alcohol       Date:  2017-03-23

Review 2.  Does tobacco use cause psychosis? Systematic review and meta-analysis.

Authors:  Pedro Gurillo; Sameer Jauhar; Robin M Murray; James H MacCabe
Journal:  Lancet Psychiatry       Date:  2015-07-09       Impact factor: 27.083

3.  Why does age of onset predict clinical severity in schizophrenia? A multiplex extended pedigree study.

Authors:  Christie W Musket; Susan S Kuo; Petra E Rupert; Laura Almasy; Ruben C Gur; Konasale Prasad; Joel Wood; David R Roalf; Raquel E Gur; Vishwajit L Nimgaonkar; Michael F Pogue-Geile
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2020-08-19       Impact factor: 3.568

Review 4.  Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis.

Authors:  Toby Pillinger; Katherine Beck; Brendon Stubbs; Oliver D Howes
Journal:  Br J Psychiatry       Date:  2017-10-05       Impact factor: 9.319

Review 5.  Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies.

Authors:  Marco Solmi; Joaquim Radua; Miriam Olivola; Enrico Croce; Livia Soardo; Gonzalo Salazar de Pablo; Jae Il Shin; James B Kirkbride; Peter Jones; Jae Han Kim; Jong Yeob Kim; Andrè F Carvalho; Mary V Seeman; Christoph U Correll; Paolo Fusar-Poli
Journal:  Mol Psychiatry       Date:  2021-06-02       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.